Alaaeldin Pediatrics, P.C.
Alaaeldin Pediatrics, P.C. was paid $652K by Medicaid between Jan 2018 and Dec 2024, across 55 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 21% of everything it billed.
33Billing provider infoALAAELDIN PEDIATRICS, P.C.
WEST BABYLON, NY 11704
WEST BABYLON, NY 11704
33aNPI1093033904assigned 05/17/2010
33bProvider typeSpecialist
28Total paid$652K
24GClaims48,723
24DCodes billed55
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Specialist providers in New York
Rank by total paid#203 of 1,221
Median peer was paid$45K
This provider vs. median14×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 7,170 | $209K | |
| 2019 | 5,389 | $133K | |
| 2020 | 5,097 | $85K | |
| 2021 | 9,108 | $131K | |
| 2022 | 5,619 | $34K | |
| 2023 | 6,592 | $23K | |
| 2024incomplete | 9,748 | $37K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 21% | 4,439 | 4,167 | $134K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 15% | 2,609 | 2,490 | $101K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 13% | 4,534 | 4,406 | $85K |
| 92567 | 12% | 6,247 | 5,894 | $77K | |
| 92552 | 7.2% | 3,370 | 3,263 | $47K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 6.8% | 1,453 | 1,444 | $45K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 5.0% | 1,089 | 1,084 | $33K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 3.8% | 897 | 891 | $25K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.7% | 662 | 653 | $18K |
| 69210 | 2.3% | 358 | 350 | $15K | |
| 92081 | 2.0% | 2,396 | 2,389 | $13K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.6% | 2,632 | 2,606 | $11K |
43 more codes
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.6% | 463 | $10K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 1.5% | 233 | $10K |
| 36415 | Collection of venous blood by venipuncture | 1.1% | 4,543 | $7K |
| 86580 | <1% | 663 | $5K | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 822 | $4K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,088 | $3K |
| 81002 | <1% | 1,712 | $2K | |
| 96127 | <1% | 872 | $2K | |
| 87070 | <1% | 965 | $1K | |
| 87110 | <1% | 214 | $1K | |
| 83655 | <1% | 430 | $902.32 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 162 | $788.28 |
| 81000 | <1% | 1,259 | $460.59 | |
| 90658 | <1% | 1,025 | $308.13 | |
| 99381 | <1% | 12 | $247.37 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 15 | $242.40 |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 248 | $210.00 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 278 | $125.79 |
| 90734 | <1% | 186 | $92.98 | |
| 81001 | <1% | 556 | $78.56 | |
| 36410 | <1% | 475 | $44.34 | |
| 90655 | <1% | 13 | $43.04 | |
| 90680 | <1% | 100 | $35.00 | |
| 90698 | 0% | 28 | $0.00 | |
| 90686 | 0% | 19 | $0.00 | |
| 90620 | 0% | 58 | $0.00 | |
| 90744 | 0% | 24 | $0.00 | |
| 90716 | 0% | 24 | $0.00 | |
| 90697 | 0% | 14 | $0.00 | |
| 90696 | 0% | 12 | $0.00 | |
| 90649 | 0% | 324 | $0.00 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 0% | 28 | $0.00 |
| 90671 | 0% | 76 | $0.00 | |
| 90670 | 0% | 295 | $0.00 | |
| 90633 | 0% | 287 | $0.00 | |
| 90707 | 0% | 13 | $0.00 | |
| 3725F | 0% | 282 | $0.00 | |
| 90715 | 0% | 60 | $0.00 | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 0% | 30 | $0.00 |
| 90461 | 0% | 24 | $0.00 | |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | 0% | 30 | $0.00 |
| 99203 | Doctor's office visit, new patient (routine) | 0% | 28 | $0.00 |
| 90710 | 0% | 47 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMOAWAD, ALAAELDIN (MEDICAL DIRECTOR)
| Provider | Location | Paid |
|---|---|---|
| Long Island Pediatrics of Brentwood,p.C. | Brentwood, NY | $3.15M |
| Long Island Medical of Amityville PC | Amityville, NY | $8K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.